Works about PROTEIN-tyrosine kinases
Results: 5000
Multimodal Adaptations to Expiratory Musculature-Targeted Resistance Training: A Preliminary Study in Healthy Young Adults.
- Published in:
- Journal of Speech, Language & Hearing Research, 2025, v. 68, n. 3, p. 987, doi. 10.1044/2024_JSLHR-24-00294
- By:
- Publication type:
- Article
Case report: A patient with EGFR L861Q positive adenosquamous lung carcinoma transforming into large cell neuroendocrine cancer after treatment with Almonertinib.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1453066
- By:
- Publication type:
- Article
Functional Remediation Improves Serum BDNF and TrkB Levels in Euthymic Patients with Bipolar Disorder: A Randomized Trial Study.
- Published in:
- Neuropsychiatric Disease & Treatment, 2025, v. 21, p. 115, doi. 10.2147/NDT.S502176
- By:
- Publication type:
- Article
Synthesis, Characterization, and In Vitro Anticancer Studies of New 1,8-Naphthyridine Substituted Schiff Base Derivatives and Their Molecular Docking.
- Published in:
- Russian Journal of General Chemistry, 2025, v. 95, n. 1, p. 209, doi. 10.1134/S1070363224609062
- By:
- Publication type:
- Article
Design, Synthesis, In Vitro Anticancer and ADMET Studies of Piperazine-Pyrazolo-Quinoxalin-2(1H)-one Conjugate as EGFR Targeting Agents.
- Published in:
- Russian Journal of General Chemistry, 2025, v. 95, n. 1, p. 184, doi. 10.1134/S1070363224610366
- By:
- Publication type:
- Article
The Role of Clinicopathological Features in Tyrosine Kinase Inhibitory Duration in EGFR Mutant Metastatic Non-Small Cell Lung Cancer.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1149, doi. 10.3390/jcm14041149
- By:
- Publication type:
- Article
Correction: Zhao et al. Fasciola gigantica Recombinant Abelson Tyrosine Protein Kinase (r Fg Abl) Regulates Various Functions of Buffalo Peripheral Blood Mononuclear Cells. Animals 2025, 15 , 179.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Whole exome sequencing analysis of a patient with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions with ETV6::LYN fusion gene.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 809, doi. 10.1007/s00277-024-06135-7
- By:
- Publication type:
- Article
Relative Quantitation of EFNA1 Expression in Mouse Heart Tissue Histologic Sections Using MALDI-MSI.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1398, doi. 10.3390/ijms26041398
- By:
- Publication type:
- Article
NTRK rearranged spindle cell neoplasm of the uterine cervix: a rare case report and literature review.
- Published in:
- BMC Women's Health, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12905-025-03574-w
- By:
- Publication type:
- Article
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning.
- Published in:
- eLife, 2025, p. 1, doi. 10.7554/eLife.101882
- By:
- Publication type:
- Article
Roles of EphA2 Receptor in Angiogenesis Signaling Pathway of Glioblastoma Multiforme.
- Published in:
- Malaysian Journal of Medical Sciences, 2018, v. 25, n. 6, p. 22, doi. 10.21315/mjms2018.25.6.3
- By:
- Publication type:
- Article
LOW INCIDENCE OF FLT3 GENE MUTATION IN MALAY PATIENTS WITH ACUTE MYELOID LEUKEMIA.
- Published in:
- Malaysian Journal of Medical Sciences, 2008, p. 129
- By:
- Publication type:
- Article
FLT3 GENE INTERNAL TANDEM DUPLICATION IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS.
- Published in:
- Malaysian Journal of Medical Sciences, 2007, v. 14, p. 43
- By:
- Publication type:
- Article
C-KIT EXPRESSION IN SYNOVIAL SARCOMAS.
- Published in:
- Malaysian Journal of Medical Sciences, 2006, v. 13, p. 186
- By:
- Publication type:
- Article
Low Stability and a Conserved N-Glycosylation Site Are Associated with Regulation of the Discoidin Domain Receptor Family by Glucose via Post-Translational N-Glycosylation.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2013, v. 77, n. 9, p. 1907, doi. 10.1271/bbb.130351
- By:
- Publication type:
- Article
A Silent Mutation Made Possible Efficient Production of Active Human Frk Tyrosine Kinase in Escherichia coli.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2010, v. 74, n. 1, p. 125, doi. 10.1271/bbb.90648
- By:
- Publication type:
- Article
The Inhibitory Mechanisms of the Tyrosine Kinase Inhibitors Herbimycin A, Genistein, and Tyrphostin B48 with Regard to the Function of the Aryl Hydrocarbon Receptor in Caco-2 Cells.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2010, v. 74, n. 1, p. 36, doi. 10.1271/bbb.90438
- By:
- Publication type:
- Article
Renal Cancer.
- Published in:
- Current Medical Literature: Urology, 2011, v. 17, n. 2, p. 51
- By:
- Publication type:
- Article
Expression frequency of c‐kit isoforms and its prognostic potential in canine mammary tumours.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 3, p. 303, doi. 10.1111/vco.12549
- By:
- Publication type:
- Article
Investigation of thyroid function in dogs treated with the tyrosine kinase inhibitor toceranib.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 3, p. 433, doi. 10.1111/vco.12538
- By:
- Publication type:
- Article
Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 2, p. 169, doi. 10.1111/vco.12525
- By:
- Publication type:
- Article
In vitro and in vivo effects of toceranib phosphate on canine osteosarcoma cell lines and xenograft orthotopic models.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 1, p. 117, doi. 10.1111/vco.12562
- By:
- Publication type:
- Article
Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.
- Published in:
- Veterinary & Comparative Oncology, 2019, v. 17, n. 4, p. 553, doi. 10.1111/vco.12520
- By:
- Publication type:
- Article
Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E117, doi. 10.1111/vco.12344
- By:
- Publication type:
- Article
Association of prognostic features and treatment on survival time of dogs with systemic mastocytosis: A retrospective analysis of 40 dogs.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E194, doi. 10.1111/vco.12373
- By:
- Publication type:
- Article
Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E23, doi. 10.1111/vco.12328
- By:
- Publication type:
- Article
The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 2, p. 632, doi. 10.1111/vco.12207
- By:
- Publication type:
- Article
Assessment of predictive molecular variables in feline oral squamous cell carcinoma treated with stereotactic radiation therapy.
- Published in:
- Veterinary & Comparative Oncology, 2016, v. 14, n. 1, p. 39, doi. 10.1111/vco.12050
- By:
- Publication type:
- Article
Met interacts with EGFR and Ron in canine osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2013, v. 11, n. 2, p. 124, doi. 10.1111/j.1476-5829.2011.00309.x
- By:
- Publication type:
- Article
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study
- Published in:
- Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 184, doi. 10.1111/j.1476-5829.2011.00265.x
- By:
- Publication type:
- Article
Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
- Published in:
- Veterinary & Comparative Oncology, 2011, v. 9, n. 3, p. 219, doi. 10.1111/j.1476-5829.2010.00253.x
- By:
- Publication type:
- Article
Epidermal growth factor enhances the malignant phenotype in canine mammary carcinoma cell lines.
- Published in:
- Veterinary & Comparative Oncology, 2011, v. 9, n. 3, p. 196, doi. 10.1111/j.1476-5829.2010.00248.x
- By:
- Publication type:
- Article
Epidermal growth factor receptor as a therapeutic target in veterinary oncology.
- Published in:
- Veterinary & Comparative Oncology, 2011, v. 9, n. 2, p. 81, doi. 10.1111/j.1476-5829.2010.00237.x
- By:
- Publication type:
- Article
Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 3, p. 209, doi. 10.1111/j.1476-5829.2010.00223.x
- By:
- Publication type:
- Article
A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2007, v. 5, n. 3, p. 177, doi. 10.1111/j.1476-5829.2007.00137.x
- By:
- Publication type:
- Article
Expression of receptor tyrosine kinases VEGFR-1 (FLT-1), VEGFR-2 (KDR), EGFR-1, PDGFRa and c-Met in canine primary brain tumours.
- Published in:
- Veterinary & Comparative Oncology, 2006, v. 4, n. 3, p. 132, doi. 10.1111/j.1476-5829.2006.00101.x
- By:
- Publication type:
- Article
RT-PCR based Tyrosine Kinase Display Profiling of Canine Melanoma: IGF-1 Receptor as a Potential Therapeutic Target.
- Published in:
- Veterinary & Comparative Oncology, 2005, v. 3, n. 1, p. 57, doi. 10.1111/j.1476-5810.2005.064am.x
- By:
- Publication type:
- Article
Immunohistochemical Differentiation and Clinicopathological Features of Canine Gastrointestinal Stromal Tumors and Leiomyosarcomas.
- Published in:
- Veterinary & Comparative Oncology, 2005, v. 3, n. 1, p. 34, doi. 10.1111/j.1476-5810.2005.0064e.x
- By:
- Publication type:
- Article
Neuregulin-1 enhances differentiation of cardiomyocytes from embryonic stem cells.
- Published in:
- Medical & Biological Engineering & Computing, 2009, v. 47, n. 1, p. 41, doi. 10.1007/s11517-008-0383-2
- By:
- Publication type:
- Article
Glycan Modulation of Insulin‐like Growth Factor‐1 Receptor.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 49, p. 1, doi. 10.1002/ange.202211320
- By:
- Publication type:
- Article
Synergy and Antagonism between Allosteric and Active‐Site Inhibitors of Abl Tyrosine Kinase.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 37, p. 20358, doi. 10.1002/ange.202105351
- By:
- Publication type:
- Article
Design of Turn‐On Near‐Infrared Fluorescent Probes for Highly Sensitive and Selective Monitoring of Biopolymers.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 22, p. 8518, doi. 10.1002/ange.202000108
- By:
- Publication type:
- Article
Directed Evolution of a Designer Enzyme Featuring an Unnatural Catalytic Amino Acid.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 7, p. 2105, doi. 10.1002/ange.201813499
- By:
- Publication type:
- Article
Morphine Prevents Ischemia/Reperfusion-Induced Myocardial Mitochondrial Damage by Activating δ-opioid Receptor/EGFR/ROS Pathway.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 841, doi. 10.1007/s10557-021-07215-w
- By:
- Publication type:
- Article
Anterior patterning genes induced by Zic1 are sensitive to retinoic acid and its metabolite, 4‐oxo‐RA.
- Published in:
- Developmental Dynamics, 2022, v. 251, n. 3, p. 498, doi. 10.1002/dvdy.420
- By:
- Publication type:
- Article
Stage‐dependent craniofacial defects resulting from Sprouty2 overexpression.
- Published in:
- Developmental Dynamics, 2007, v. 236, n. 7, p. 1918, doi. 10.1002/dvdy.21195
- By:
- Publication type:
- Article
Raman identification of single cell component and FMS‐like tyrosine kinase 3‐internal tandem duplications subtype for clinical acute myeloid leukemia.
- Published in:
- Journal of Raman Spectroscopy, 2023, v. 54, n. 6, p. 596, doi. 10.1002/jrs.6523
- By:
- Publication type:
- Article
Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 6, p. 674, doi. 10.1007/s10157-021-02038-3
- By:
- Publication type:
- Article
Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.
- Published in:
- Clinical & Experimental Nephrology, 2017, v. 21, n. 6, p. 952, doi. 10.1007/s10157-017-1386-9
- By:
- Publication type:
- Article